Waters and BD will merge biosciences and diagnostics in a $17.5B deal via Reverse Morris Trust, creating a life sciences ...

Twist Bioscience posted 23% year-over-year sales growth and beat EPS expectations in its most recent quarter. Click here to ...

Waters Corporation is merging with BD’s Biosciences and Diagnostic Solutions business in a $17.5 billion deal to expand its capabilities in life sciences and diagnostics.

A familiar face in the local biotech scene steps into the CFO role at Neuronetics, fresh off guiding a company through a successful product launch.

Five acquisitions in 2025—including Cargo and Allakos—have put Concentra Biosciences in the spotlight. Learn what’s behind ...

Becton, Dickinson's divestment enhances focus, reduces leverage, funds buybacks, and unlocks value. Read more about the M&A ...

BURLINGTON - MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, confirmed Neoclease as the winner of the 2025 North ...

Partnership established to develop and scale production of ATL-105, a novel recombinant version of alpha-1 antitrypsin ...

This stock used to be a highflyer but has struggled in recent years as demand waned for its flagship product. Though Moderna ...

Australian biotech giant CSL Ltd said on Tuesday it plans to trim its research and development division across six global locations and would rely more on external partnerships, a move that will cut ...

Waters plans to combine with the Biosciences & Diagnostic Solutions business of BD (Becton, Dickinson & Co.), the companies said, in a $17.5 billion deal that would be the year’s largest within life ...

Gov. Andy Beshear announced Monday Lexington-based Meridian Biotech is partnering with Buffalo Trace Distillery to build a ...